There is a massive pipe-line of R&D and product development across applications I have never heard of before (drug delivery).
The drug delivery device PNV is developing deserves attention, imo.
With the proviso that most “market research” reports need to be taken with a rather large grain of salt, these excerpts below, which have been drawn from from two different reports on the implantable drug eluting device market, provide a glimpse into the potential of this particular market.
https://www.futuremarketinsights.com/reports/implantable-drug-eluting-devices-market
- Growing incidence of chronic diseases, coupled with rising demand for minimally invasive treatment options, is driving the market for implantable drug delivery devices.
- Implantable drug-eluting devices provide localized and site-specific drug delivery which is especially important in applications such as oncology, cardiology, and opioid addiction treatment.
- These devices assure improved patient compliance that has been one of the longstanding challenges for healthcare providers.
- Bioresorbable drug eluting devices have emerged as the fourth revolution in interventional cardiology owing to potential advantages.
- Contraceptive drug-eluting devices currently account for 2/5th share in the global market revenue.
- Advent of biodegradable implants enables targeted delivery of chemotherapeutics to tumor cells without damaging normal cells.
- Autoimmune diseases….are expected to exhibit the fastest CAGR owing to rising prevalence of multiple sclerosis and rheumatoid arthritis.
- The demand for biodegradable drug-eluting stents is expected to climb in the near future…
- The global implantable drug-eluting devices market is expected to surpass the US$ 10 Bn mark by 2019 end.
- The global implantable drug delivery devices market size is expected to reach USD 31.6 billion by 2025, registering a 7.5% CAGR during the forecast period.
https://www.prnewswire.com/news-rel...arket-2018---forecast-to-2025--300702024.html
- Forums
- ASX - By Stock
- Pipeline
PNV
polynovo limited
Add to My Watchlist
0.42%
!
$1.20

There is a massive pipe-line of R&D and product development...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.20 |
Change
0.005(0.42%) |
Mkt cap ! $829.0M |
Open | High | Low | Value | Volume |
$1.21 | $1.24 | $1.19 | $1.649M | 1.366M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16990 | $1.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.21 | 9989 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16990 | 1.200 |
1 | 25000 | 1.195 |
4 | 87354 | 1.190 |
2 | 12607 | 1.185 |
2 | 13048 | 1.180 |
Price($) | Vol. | No. |
---|---|---|
1.210 | 9989 | 1 |
1.215 | 9083 | 1 |
1.220 | 9083 | 1 |
1.225 | 63084 | 2 |
1.230 | 30723 | 4 |
Last trade - 16.10pm 01/07/2025 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online